Costello LC, Franklin RB. A proposed efficacious treatment with clioquinol (zinc ionophore) and cabergoline (prolaction dopamine agonist) for the treatment of terminal androgen-independent prostate cancer. Why and how? J Clin Oncol 2019; 2(1): 1-15.
Russl-Jones GJ, Luke MR, Himes SR. Transdermal delivery of pharmaceutical agents. US20070243132. (2007).
LeMahieu E, Jones C, Stern T, et al. Methods and systems of delivering medication via inhalation. US20080066741. (2008).
Maksoud YAA, Maher MA. Pharmaceutical compositions for intranasal administration for the treatment of neurodegenerative disorders. US8987199. (2015).
Castaigne J, Demeule M, Che C, Regina A. Compositions and methods for the transport of therapeutic agents. WO2011041897. (2011).
Bezwada RS. Control release of biologically active compounds from multi-armed oligomers. US8026285. (2011).
Tsien R, Aguilera T, Olson E, Jiang T, Nguyen Q. Peptides whose uptake in cells is controllable. US9682151. (2017).
Emanuel N. Sustained-release drug carrier composition. US10105443. (2018).
Schutt EG, McGuire RW, Walter PA, Los KDA. Method for formulating large diameter synthetic membrane vesicles. US980842. (2017).
Lind SE, Ding W. Ionophores as a cancer chemotherapeutic agents. US20060040980. (2006).
Laughlin M, Anderson MB, Willardsen A, Pleiman C. Methods of treating cancer. US20100093773. (2010).
Tsai C. Hydroxylated tolans and related compounds in the treatment of a cancer. US8716355. (2014).
Xilinas M. Method for treating cancer, coronary, inflammatory, and macular disease, combining the modulation of zinc and/or copper dependent proteins. US20080207673. (2008).
Mumper RJ, Gupte A, Wadhwa S. Polymer-metal chelator conjugates and uses thereof. US20090092664. (2009).
Gomis R, Arnal A, Pavlovic M, Tarragona M. Method of designing a therapy for breast cancer metastasis. EP3091085. (2011).
Gomis R, Planet E, Pavlovic M, Arnal A, Tarragona M. Method for the prognosis and treatment of metastasizing cancer of the bone originating from breast cancer. EP3055429. (2014).
Schimmer AD, Mao X, Steward K. Clioquinol for the treatment of hematological malignancies. US20110123617. (2011).
Schimmer AD, Li X, Batey R, Wood T, Mao X. 8- Hydroxyquinolin derivatives for the treatment of hematoligcal malignancies. US20110144155. (2011).
Gajewski TF, Sivan A, Corrales L. Treatment of cancer by manipulation of commensal microflora. US98553202. (2018).
Chigaev A, Sklar LA, Perez D. Method for cancer cell reprogramming. US9314460. (2016).